Event Details

This webinar will review the co-use of alcohol and/or other substance with commercial tobacco and nicotine, the health effects of this co-use, and the impact of co-use on smoking cessation outcomes.

The session will investigate treatment protocols of tobacco use for individuals with alcohol or other substance use.

Intended audience: Public health practitioners, health care professionals, those interested in learning more about commercial tobacco and nicotine cessation services and programs.

By the end of this session, participants will be able to:

• Explain the biopsychosocial determinants of co-use of alcohol and other substances with tobacco and nicotine. 
• Describe the health effects of co-use. 
• Situate the role of co-use on smoking cessation outcomes. 
• Discuss concurrent versus sequential treatment of tobacco use in those with alcohol or other substance use disorders.
  
  

Dr. Peter Selby MBBS, CCFP, FCFP, MHSc, DFASAM is a Senior Scientist and Senior Medical Consultant at the Centre for Addiction and Mental Health (CAMH). He is the Vice-Chair, Research and Giblon Professor in Family Medicine, University of Toronto. His research focuses on innovative methods to understand and treat addictive behaviours and their comorbidities. He uses technology to combine clinical medicine and public health methods to scale up and test health interventions.  

The opinions expressed by speakers and moderators do not necessarily reflect the official policies or views of Public Health Ontario, nor does the mention of trade names, commercial practices, or organizations imply endorsement by Public Health Ontario.

Public Health Ontario is committed to complying with the Accessibility for Ontarians with Disabilities Act (AODA). If you require accommodations to participate in this event, please contact 647-260-7100 or capacitybuilding@oahpp.ca.